Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study
Pharmacology, Toxicology and Pharmaceutical Science
1
5%
Immunology and Microbiology
1
5%
Medicine and Dentistry
1
5%
Unknown
13
65%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2024.
All research outputs
#10,313,054
of 32,394,374 outputs
Outputs from Cancers
#5,473
of 19,234 outputs
Outputs of similar age
#155,805
of 522,383 outputs
Outputs of similar age from Cancers
#229
of 1,000 outputs
Altmetric has tracked 32,394,374 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 19,234 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 522,383 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 1,000 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.
